blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2141227

EP2141227 - Hyperblebbing bacterial strains and use thereof for production of vaccines [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  12.10.2012
Database last updated on 14.11.2024
Most recent event   Tooltip12.10.2012Withdrawal of applicationpublished on 14.11.2012  [2012/46]
Applicant(s)For all designated states
SmithKline Beecham Biologicals S.A.
Rue de l'Institut 89
1330 Rixensart / BE
[N/P]
Former [2010/01]For all designated states
SmithKline Beecham Biologicals S.A.
Rue de l'Institut 89
1330 Rixensart / DE
Inventor(s)01 / Berthet, Francois-Xavier Jacques
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
02 / Denoel, Philippe
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
03 / Neyt, Cecile Anne
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
04 / Poolman, Jan
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
05 / Thonnard, Joelle
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
 [2010/01]
Representative(s)Lubienski, Michael John, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 8GS / GB
[N/P]
Former [2010/01]Lubienski, Michael John, et al
GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date09165364.208.02.2002
[2010/01]
Priority number, dateGB2001000317108.02.2001         Original published format: GB 0103171
[2010/01]
Previously filed application, dateEP2002070021908.02.2002
[2010/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2141227
Date:06.01.2010
Language:EN
[2010/01]
Type: A3 Search report 
No.:EP2141227
Date:11.08.2010
[2010/32]
Search report(s)(Supplementary) European search report - dispatched on:EP13.07.2010
ClassificationIPC:C12N1/21, C07K14/22, C07K14/285, C07K14/195, A61K39/095, A61K39/10, A61K39/102, A61K39/104, A61K39/106
[2010/01]
CPC:
C07K14/285 (EP,US); A61P31/04 (EP); C07K14/195 (EP,US);
C07K14/22 (EP,US); C12N1/20 (EP,US); A61K2039/52 (EP,US);
Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2010/01]
TitleGerman:Hyperblebbing" bakterielle Stämme und ihre Verwendung zur Herstellung von Impfstoffen[2010/01]
English:Hyperblebbing bacterial strains and use thereof for production of vaccines[2010/01]
French:Souches bacteriénnes "hyperbleb" et leur utilisation pour la production de vaccins[2010/01]
Examination procedure14.07.2009Examination requested  [2010/01]
11.02.2011Amendment by applicant (claims and/or description)
17.03.2011Despatch of a communication from the examining division (Time limit: M06)
27.09.2011Reply to a communication from the examining division
04.10.2012Application withdrawn by applicant  [2012/46]
04.10.2012Cancellation of oral proceeding that was planned for 19.10.2012
19.10.2012Date of oral proceedings (cancelled)
Parent application(s)   TooltipEP02700219.5  / EP1357938
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020700219) is  08.03.2007
Fees paidRenewal fee
14.07.2009Renewal fee patent year 03
14.07.2009Renewal fee patent year 04
14.07.2009Renewal fee patent year 05
14.07.2009Renewal fee patent year 06
14.07.2009Renewal fee patent year 07
14.07.2009Renewal fee patent year 08
08.02.2010Renewal fee patent year 09
08.02.2011Renewal fee patent year 10
07.02.2012Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9705899  (UNIV GUELPH [CA], et al) [A] 1,2,4,7-16 * page 2, line 36 - page 3, line 4 * * page 6, line 34 - page 8, line 7 ** page 37; table 1 *;
 [A]WO9959625  (UNIV MARYLAND [US]) [A] 1-4,7-16 * the whole document * * page 13 *;
 [Y]  - BERNADAC ALAIN ET AL, "Escherichia coli tol-pal mutants form outer membrane vesicles.", JOURNAL OF BACTERIOLOGY, (1998), vol. 180, no. 18, ISSN 0021-9193, pages 4872 - 4878, XP002208245 [Y] 1-4,7,16 * abstract * * page 4877, column L, paragraph L *
 [Y]  - SEN K ET AL, "Isolation and characterization of the Haemophilus influenzae tolQ, tolR, tolA and tolB genes", GENE, ELSEVIER, AMSTERDAM, NL, (19961031), vol. 178, no. 1, ISSN 0378-1119, pages 75 - 81, XP004043342 [Y] 1-4,7,16 * abstract * * page 75, column l, paragraph 2 - column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/0378-1119(96)00338-1
 [Y]  - LLAMAS MARIA A ET AL, "Mutations in each of the Tol genes of Pseudomonas putida reveal that they are critical for maintenance of outer membrane stability.", JOURNAL OF BACTERIOLOGY, (200009), vol. 182, no. 17, ISSN 0021-9193, pages 4764 - 4772, XP002208246 [Y] 1-4,7,16 * page 4765, column L, paragraph 2 * * page 4771, column L, paragraph 2 *

DOI:   http://dx.doi.org/10.1128/JB.182.17.4764-4772.2000
 [Y]  - FORTNEY KATE R ET AL, "Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection", INFECTION AND IMMUNITY, (200011), vol. 68, no. 11, ISSN 0019-9567, pages 6441 - 6448, XP002587885 [Y] 1,2,4,7,16 * abstract * * page 6441, column r, paragraph 2 - page 6442, column l, paragraph 3 * * page 6443, column l, paragraph 1 - paragraph 4 *
 [XI]  - HARADA T ET AL, "IMMUNOLOGICAL RESPONSE TO OUTER MEMBRANE VESICLES OF HAEMOPHILUS INFLUENZAE IN PATIENTS WITH ACUTE SINUSITIS", RHINOLOGY, INTERNATIONAL RHINOLOGIC SOCIETY, NL, (19860301), vol. 24, no. 1, ISSN 0300-0729, pages 61 - 66, XP000960783 [X] 8,11-15 * page 62, paragraph 2 * [I] 9,10
 [A]  - STURGIS JAMES N, "Organisation and evolution of the tol-pal gene cluster.", JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY, January, 2001, (200101), vol. 3, no. 1, ISSN 1464-1801, pages 113 - 122, XP001089625 [A] 1-3,7-16 * page 115, column l, paragraph 4 - page 116, column r, paragraph 1; figure 2 * * page 120, column l, paragraph 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.